Aldosterone in salt-sensitive hypertension and metabolic syndrome.
about
Exercise induced adipokine changes and the metabolic syndromeOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusReactive oxygen species and dopamine receptor function in essential hypertensionAnalysis of metabolites in plasma reveals distinct metabolic features between Dahl salt-sensitive rats and consomic SS.13(BN) rats.The metabolic syndrome and risk of chronic kidney disease: pathophysiology and intervention strategies.Obesity and renovascular disease.Exercise in the metabolic syndrome.Hypertension as part of the metabolic syndrome.The Association between Oxidative Stress and Metabolic Syndrome in Adults.Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy.Ambient tonicity and intestinal cytochrome CYP3A.From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.The metabolic syndrome and chronic kidney disease.Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.The LRP1 Gene Polymorphism is associated with Increased Risk of Metabolic Syndrome Prevalence in the Serbian Population.Feedforward activation of endothelial ENaC by high sodium.Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.Effect of high fat loading in Dahl salt-sensitive rats.Hindbrain mineralocorticoid mechanisms on sodium appetite.Anti-obesity effects of Taif and Egyptian pomegranates: molecular study.Genomic and rapid effects of aldosterone: what we know and do not know thus far.The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
P2860
Q26822992-3312C40F-E8DA-42BA-B1E6-6B2015FA0210Q26829529-DD9729BE-8330-4B65-83CB-0C5561D33E7CQ34971057-773185F5-DBC0-46E6-A507-2213FAFC804BQ35581002-E63664F2-4745-43CA-9CB4-B9C6E7EE5A5DQ35864666-59EF93CC-8320-4280-822A-1408DF94EDABQ35958492-024B2055-0C04-4A33-B178-AE404DE6783BQ36102382-47BCD5EA-6336-49C5-93C6-0CC861D3EDA9Q37189315-4A7AE88C-EC0F-4BBF-8462-0B3B6F581018Q37376045-CC13D85E-7D3A-4A3A-985A-18372ED889CCQ37720499-48EAA7F5-BAAA-422E-96F4-D765AD42EF07Q37725997-7CA97897-1CA2-48BB-99EC-E8B51D5442C8Q37786549-FB565BC5-99B3-4566-B3D2-F4972D97EF12Q39056509-A2EE8CAE-E7AD-4A83-8A06-5E320C40CC44Q39387327-AD8B7656-2BBF-4FC5-A206-D725A607E5DEQ39635951-DE8E3A58-EBA1-416E-AED4-7932A1BF8882Q40737068-748B0A27-6FE5-4F48-A5DC-9CD03A825551Q41155887-D08462AA-5C27-4A3A-BF90-3350D8D82BC3Q42291112-ED8014EC-434C-4806-AA81-75ED7B4EEC2DQ43064232-46B0325C-2792-4E13-A070-CCB73561C732Q43065467-3C6BF009-B501-4BEA-B165-50495A61E96EQ45798876-FE2BD1CF-393B-4949-911D-951EC0AF8915Q50456804-A35C3903-FD39-42BE-85F2-077F62236E54Q51273122-DC358664-AB9F-4FEF-9ABD-336D6D9EDD9EQ53685411-34FAF9DC-6C87-4722-A8AA-F57BFE9FED33
P2860
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@ast
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@en
type
label
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@ast
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@en
prefLabel
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@ast
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@en
P1476
Aldosterone in salt-sensitive hypertension and metabolic syndrome.
@en
P2093
Toshiro Fujita
P2888
P304
P356
10.1007/S00109-008-0343-1
P577
2008-04-25T00:00:00Z
P6179
1043105201